Furthermore, high GLS activity does not always mirror lower glutamine synthetic capacity, as in the case of non-small cell lung cancer (NSCLC), in which the expression levels of GLS and GS are both high [81]. This evidence concerns the gene GLUL and non-small cell lung carcinoma.